Pharmacokinetics of Nirmatrelvir and Ritonavir in COVID-19 Patients with End-Stage Renal Disease on Intermittent Hemodialysis

被引：24

作者：

Lingscheid, Tilman ^{[1
,2
,3
]}

Kinzig, Martina ^{[4
]}

Krueger, Anne ^{[2
,3
,5
]}

Mueller, Nils ^{[2
,3
,5
]}

Boelke, Georg ^{[2
,3
,5
]}

Tober-Lau, Pinkus ^{[1
,2
,3
]}

Muenn, Friederike ^{[1
,2
,3
]}

Kriedemann, Helene ^{[1
,2
,3
]}

Witzenrath, Martin ^{[1
,2
,3
,6
]}

Sander, Leif E. ^{[1
,2
,3
,6
,7
]}

Soergel, Fritz ^{[4
,8
]}

Kurth, Florian ^{[1
,2
,3
,9
]}

机构：

[1] Charite Univ Med Berlin, Dept Infect Dis & Resp Med, Berlin, Germany

[2] Free Univ Berlin, Berlin, Germany

[3] Humboldt Univ, Berlin, Germany

[4] IBMP Inst Biomed & Pharmaceut Res, Nurnberg, Germany

[5] Charite Univ Med Berlin, Dept Nephrol & Intens Care, Berlin, Germany

[6] DZL, German Ctr Lung Res, Berlin, Germany

[7] Berlin Inst Hlth, Berlin, Germany

[8] Univ Duisburg Essen, West German Heart & Vasc Ctr, Inst Pharmacol, Essen, Germany

[9] Bernhard Nocht Inst Trop Med, Dept Trop Med, Hamburg, Germany

来源：

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY | 2022年 / 66卷 / 11期

关键词：

COVID-19; end-stage renal disease; hemodialysis; nirmatrelvir/ritonavir; Paxlovid; PLASMA;

D O I：

10.1128/aac.01229-22

中图分类号：

Q93 [微生物学];

学科分类号：

071005 ; 100705 ;

摘要：

Nirmatrelvir/ritonavir is an effective antiviral therapy against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Use is not recommended in patients with end-stage renal disease (ESDR) due to a lack of data. We investigated the pharmacokinetics of nirmatrelvir/ritonavir (150 mg/100 mg twice a day) in four patients with ESRD undergoing hemodialysis. Nirmatrelvir peak concentrations ranged from 4,563 to 7,898 ng/ mL and declined after hemodialysis. Concentrations were up to 4-fold higher but still within the range known from patients without ESRD, without accumulation of nirmatrelvir after the end of treatment.

引用

页数：4

共 50 条

[21] Perception of Social Workers on the Psychosocial Issues of End-Stage Renal Disease Patients during COVID-19: A Qualitative Study
Powathil, Ginu George
Kr, Anish
SOCIAL WORK IN PUBLIC HEALTH, 2022, 37 (07) : 679 - 691
[22] Oral Nirmatrelvir and Ritonavir in Nonhospitalized Vaccinated Patients With Coronavirus Disease 2019 (COVID-19)
Ganatra, Sarju
Dani, Sourbha S.
Ahmad, Javaria
Kumar, Ashish
Shah, Jui
Abraham, George M.
McQuillen, Daniel P.
Wachter, Robert M.
Sax, Paul E.
CLINICAL INFECTIOUS DISEASES, 2023, 76 (04) : 563 - 572
[23] PHARMACOKINETICS OF ZIDOVUDINE IN END-STAGE RENAL-DISEASE - INFLUENCE OF HEMODIALYSIS
PACHON, J
CISNEROS, JM
CASTILLO, JR
GARCIAPESQUERA, F
CANAS, E
VICIANA, P
AIDS, 1992, 6 (08) : 827 - 830
[24] Adherence to hemodialysis and medical regimens among patients with end-stage renal disease during COVID-19 pandemic: a cross-sectional study
Sultan, Basma Osman
Fouad, Ahmed Mahmoud
Zaki, Heba M.
BMC NEPHROLOGY, 2022, 23 (01)
[25] Adherence to hemodialysis and medical regimens among patients with end-stage renal disease during COVID-19 pandemic: a cross-sectional study
Basma Osman Sultan
Ahmed Mahmoud Fouad
Heba M. Zaki
BMC Nephrology, 23
[26] The Evaluation of the Periodontal Status of Hemodialysis Patients with End-Stage Renal Disease
Dembowska, Elzbieta
Jaron, Aleksandra
Raslawska-Socha, Joanna
Gabrysz-Trybek, Ewa
Bladowska, Joanna
Gacek, Szymon
Trybek, Grzegorz
JOURNAL OF CLINICAL MEDICINE, 2022, 11 (04)
[27] Dosing of gentamicin in patients with end-stage renal disease receiving hemodialysis
Teigen, Mette Maja B.
Duffull, Stephen
Dang, Lily
Johnson, David W.
JOURNAL OF CLINICAL PHARMACOLOGY, 2006, 46 (11) : 1259 - 1267
[28] Ocular changes during hemodialysis in patients with end-stage renal disease
Chen, Hejun
Zhang, Xi
Shen, Xi
BMC OPHTHALMOLOGY, 2018, 18
[29] The Efficacy and Safety of Nirmatrelvir/Ritonavir Against COVID-19 in Elderly Patients
Xiang, Zheng
Wang, Yueyuan
Qu, Yuchen
Lv, Bo
Han, Junping
Xu, Delai
Fan, Kai
Su, Cunjin
Shen, Zhu
INTERNATIONAL JOURNAL OF GENERAL MEDICINE, 2024, 17
[30] Dyspepsia and gastric emptying in end-stage renal disease patients on hemodialysis
Salles Junior, Luiz Derwal
Santos, Paulo Roberto
dos Santos, Armenio Aguiar
Loiola Ponte de Souza, Marcellus Henrique
BMC NEPHROLOGY, 2013, 14

← 1 2 3 4 5 →